D.E. Shaw & Co’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.98M | Sell |
2,800,282
-144,230
| -5% | -$205K | ﹤0.01% | 1548 |
|
|
2025
Q1 | $4.51M | Sell |
2,944,512
-349,113
| -11% | -$534K | ﹤0.01% | 1404 |
|
|
2024
Q4 | $8.17M | Sell |
3,293,625
-78,224
| -2% | -$194K | 0.01% | 1075 |
|
|
2024
Q3 | $3.88M | Buy |
3,371,849
+51,643
| +2% | +$59.4K | ﹤0.01% | 1436 |
|
|
2024
Q2 | $3.65M | Buy |
3,320,206
+37,224
| +1% | +$40.9K | ﹤0.01% | 1430 |
|
|
2024
Q1 | $4.07M | Buy |
3,282,982
+1,343,972
| +69% | +$1.67M | ﹤0.01% | 1378 |
|
|
2023
Q4 | $2.04M | Buy |
1,939,010
+1,873,000
| +2,837% | +$1.97M | ﹤0.01% | 1727 |
|
|
2023
Q3 | $452K | Buy |
66,010
+37,087
| +128% | +$254K | ﹤0.01% | 2346 |
|
|
2023
Q2 | $300K | Buy |
+28,923
| New | +$300K | ﹤0.01% | 2487 |
|
|
2022
Q1 | – | Sell |
-22,864
| Closed | -$332K | – | 4219 |
|
|
2021
Q4 | $332K | Sell |
22,864
-40,758
| -64% | -$592K | ﹤0.01% | 3276 |
|
|
2021
Q3 | $1.15M | Sell |
63,622
-205,633
| -76% | -$3.7M | ﹤0.01% | 2407 |
|
|
2021
Q2 | $4.73M | Buy |
+269,255
| New | +$4.73M | ﹤0.01% | 1479 |
|
|
2020
Q1 | – | Sell |
-69,769
| Closed | -$132K | – | 2637 |
|
|
2019
Q4 | $132K | Sell |
69,769
-631,696
| -90% | -$1.2M | ﹤0.01% | 2550 |
|
|
2019
Q3 | $758K | Buy |
701,465
+32,206
| +5% | +$34.8K | ﹤0.01% | 1945 |
|
|
2019
Q2 | $1.47M | Sell |
669,259
-1,183,610
| -64% | -$2.59M | ﹤0.01% | 1742 |
|
|
2019
Q1 | $11.1M | Sell |
1,852,869
-425,495
| -19% | -$2.55M | 0.01% | 789 |
|
|
2018
Q4 | $16.8M | Buy |
2,278,364
+950,781
| +72% | +$7.03M | 0.02% | 588 |
|
|
2018
Q3 | $19.3M | Buy |
1,327,583
+58,668
| +5% | +$852K | 0.02% | 588 |
|
|
2018
Q2 | $25.3M | Buy |
1,268,915
+30,629
| +2% | +$612K | 0.03% | 468 |
|
|
2018
Q1 | $21.7M | Buy |
1,238,286
+215,158
| +21% | +$3.77M | 0.03% | 496 |
|
|
2017
Q4 | $25.2M | Buy |
1,023,128
+1,010,970
| +8,315% | +$24.9M | 0.03% | 436 |
|
|
2017
Q3 | $314K | Buy |
+12,158
| New | +$314K | ﹤0.01% | 2217 |
|